Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

Yes, Radient's new CEO Dennis Charter is currently pursuing the Saliva Test.

Go to his wiki page:
http://en.wikipedia.org/wiki/Dennis_Charter

"In 2003 Dennis Charter invented a test for Cancer using only a small swab of Saliva from your mouth. By 2012 that Saliva Cancer Test [3] had been developed and proven in clinical trials of over 6,600 people to detect up to 20 major solid tumour cancers."

Click on that [3] in the second sentence above on the wiki page and you are sent to this shiny new piece of bait:
http://www.cst.ac/

Before May 2014, Charter had to tell prospective investors "My company AMDL Australia has a distribution agreement with the Radient -- we buy kits from Radient and use them for the Saliva Test."

When he became CEO of Radient in May 2014, Charter became the owner of the documentation, processes, and technology for manufacturing DR-70. Now he can tell prospective investors "We manufacture the DR-70 tests ourselves."

I'm skeptical about his $19 price target though. He eliminated the processes of working with blood, but undercutting GCDx by $80? Wow. That $19 price target might be just another shiny piece of bait for prospective investors.

The most telling evidence here, though, is: Notice how Charter is not working on anything to do with Radient. He is working on "Cancer Screen Technologies Limited." RXPC shareholders are not invited to this party.